HilleVax Q3 EPS $(0.81) Beats $(0.84) Estimate
Portfolio Pulse from Benzinga Newsdesk
HilleVax (NASDAQ:HLVX) reported Q3 losses of $(0.81) per share, beating the analyst consensus estimate of $(0.84) by 3.57 percent. However, this is an 80 percent increase in losses compared to $(0.45) per share from the same period last year.
November 09, 2023 | 10:13 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
HilleVax's Q3 losses were less than expected but increased significantly YoY. This mixed result may lead to uncertain market reactions.
HilleVax's Q3 earnings beat estimates, which is generally positive for the stock. However, the significant YoY increase in losses could be a concern for investors, potentially offsetting the positive impact of beating estimates. Therefore, the short-term impact on the stock is uncertain.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100